X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (736) 736
Publication (32) 32
Newsletter (17) 17
Newspaper Article (13) 13
Book Chapter (12) 12
Book Review (7) 7
Conference Proceeding (2) 2
Dissertation (2) 2
Book / eBook (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lacosamide (683) 683
index medicus (406) 406
epilepsy (370) 370
humans (341) 341
clinical neurology (308) 308
male (241) 241
anticonvulsants - therapeutic use (223) 223
seizures (222) 222
female (209) 209
efficacy (203) 203
partial-onset seizures (199) 199
antiepileptic drugs (195) 195
acetamides - therapeutic use (177) 177
adult (170) 170
neurology (163) 163
safety (159) 159
neurosciences (147) 147
middle aged (137) 137
treatment outcome (134) 134
pharmacology & pharmacy (133) 133
anticonvulsants - adverse effects (111) 111
animals (109) 109
status epilepticus (108) 108
randomized controlled-trial (106) 106
epilepsy - drug therapy (102) 102
acetamides - adverse effects (100) 100
anticonvulsants - administration & dosage (98) 98
young adult (96) 96
aged (93) 93
analysis (91) 91
adolescent (90) 90
acetamides - administration & dosage (89) 89
levetiracetam (89) 89
anticonvulsants (88) 88
oral lacosamide (87) 87
adjunctive therapy (84) 84
psychiatry (83) 83
anticonvulsants - pharmacology (82) 82
epilepsies, partial - drug therapy (82) 82
intravenous lacosamide (76) 76
care and treatment (75) 75
drug therapy (75) 75
acetamides - pharmacology (69) 69
dose-response relationship, drug (69) 69
carbamazepine (67) 67
drugs (66) 66
seizures - drug therapy (64) 64
therapy (64) 64
antiepileptic drug (63) 63
retrospective studies (62) 62
drug therapy, combination (61) 61
research (58) 58
adults (57) 57
rats (56) 56
behavioral sciences (55) 55
status epilepticus - drug therapy (55) 55
phenytoin (53) 53
refractory status epilepticus (53) 53
pharmacokinetics (52) 52
convulsive status epilepticus (51) 51
nonconvulsive status epilepticus (50) 50
medicine & public health (48) 48
lamotrigine (47) 47
tolerability (47) 47
antiepileptic agents (46) 46
aged, 80 and over (44) 44
anticonvulsants - pharmacokinetics (44) 44
dosage and administration (44) 44
double-blind (44) 44
acetamides - pharmacokinetics (43) 43
children (43) 43
convulsions & seizures (42) 42
medical research (39) 39
anticonvulsant lacosamide (38) 38
child (38) 38
neuropathic pain (38) 38
pregabalin (37) 37
refractory epilepsy (37) 37
electroencephalography (36) 36
focal epilepsy (36) 36
rats, sprague-dawley (36) 36
clinical trials (34) 34
topiramate (34) 34
adjunctive lacosamide (33) 33
mice (33) 33
slow inactivation (33) 33
valproic acid (33) 33
complications and side effects (32) 32
double-blind method (32) 32
gated sodium-channels (32) 32
management (32) 32
medicine, experimental (32) 32
gabapentin (31) 31
patients (31) 31
perampanel (31) 31
child, preschool (30) 30
disease models, animal (30) 30
pharmacotherapy (30) 30
drug resistance (29) 29
pediatrics (29) 29
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (705) 705
Spanish (25) 25
German (17) 17
Russian (12) 12
Italian (9) 9
French (5) 5
Hungarian (5) 5
Czech (2) 2
Japanese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Zeitschrift für Kristallographie - New Crystal Structures, ISSN 1433-7266, 12/2018, Volume 234, Issue 1, pp. 119 - 120
, monoclinic, (no. 4), = 10.7872(2) Å, = 5.02626(11) Å, = 15.5479(3) Å, = 94.2278(17)°, = 840.70(3) Å , = 2, ) = 0.0337, ) = 0.0871, = 293(2) K. 
1863961 | CRYSTALLOGRAPHY | LACOSAMIDE
Journal Article
Journal of the Neurological Sciences, ISSN 0022-510X, 02/2020, Volume 409, p. 116601
Lacosamide (LCM) is a new generation antiepileptic drug. It has only been available in Asia in recent years. A retrospective study at two hospitals in Hong... 
Efficacy | Tolerability | Safety | Post-marketing | Lacosamide
Journal Article
Journal Article
EPILEPSIA, ISSN 0013-9580, 05/2017, Volume 58, Issue 5, pp. 919 - 923
Objective: To compare the efficacy and safety of lacosamide (LCM) and sodium valproate (SVA) in lorazepam (LOR)-resistant status epilepticus (SE). Methods:... 
Antiepileptic drug | MANAGEMENT | EFFICACY | CONVULSIVE STATUS EPILEPTICUS | ORAL LACOSAMIDE | Mortality | Lacosamide | Adverse event | CLINICAL NEUROLOGY | PARTIAL-ONSET SEIZURES | REPLACEMENT | PHENYTOIN | INTRAVENOUS LACOSAMIDE | Lorazepam | Sodium valproate | Status epilepticus | NONCONVULSIVE STATUS EPILEPTICUS
Journal Article